The Johns Hopkins Bloomberg School has signed a partnership with IIHMR University of Jaipur regarding two online courses on Vaccine Economics. The aim of this course is to educate students about the optimization of vaccine coverage during this COVID-19 pandemic time.
Read here : IIHMR University Admission procedure, College facilities Courses and Fees
IIHMR University is offering this online course that has already received 400 applications among which 230 are shortlisted from the field of immunization and vaccine delivery. Candidates from Nepal, Myanmar, Bhutan, India, Bangladesh, and Somalia have applied for this course. From India only there are 53 participants who have got selected to attend the program out of 64 applications. The selected candidates are working in various organizations like the Ministry of Health and Family Welfare, state ministries, UNDP, UNICEF, WHO, Tata Trusts, Clinton Health Access Initiative, and IIT Kharagpur.
The Novel Coronavirus has spread over 4.76 Crore people and also claims 12.11 death cases all over the globe. And India has faced 1,24,315 death cases in total along with 83,64,086 infected people till now. As the global situation has drastically affected by the COVID-19 pandemic and the whole world is now in a wait for the vaccine, this educational concept will be proven as a ray of hope in the vaccine program. It emphasizes the need for a hearty model for the COVID vaccines, which are now under trial, especially in low and medium-income countries.
The official president of IIHMR University, P R Sodani, said that "the impact of infection rate of the disease and the economic impact is critical now. COVID-19 has created new challenges for managing the existing immunization programs along with preparing for the rapid arrangement of the upcoming COVID vaccine in the future." So, he is hoping these online courses will help immunization managers to optimize the rate of delivery of the COVID vaccines during this challenging time.
Know here : How College Admissions are affected due to COVID 19